Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Vennart

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Journal of Viral Hepatitis|October 7, 2009
Optimal combinations of ultrasound-based and serum markers of disease severity in patients with chronic hepatitis CJ F L Cobbold, M M E Crossey, P Colman, et al.
The British Journal of Radiology|October 1, 2004
Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trialsM O Leach, K M Brindle, J L Evelhoch, et al.
British Journal of Cancer|May 5, 2005
The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendationsM O Leach, K M Brindle, J L Evelhoch, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Journal of Viral Hepatitis|October 7, 2009
Optimal combinations of ultrasound-based and serum markers of disease severity in patients with chronic hepatitis CJ F L Cobbold, M M E Crossey, P Colman, et al.
The British Journal of Radiology|October 1, 2004
Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trialsM O Leach, K M Brindle, J L Evelhoch, et al.
British Journal of Cancer|May 5, 2005
The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendationsM O Leach, K M Brindle, J L Evelhoch, et al.
Pageof 4